GenomeKey is a pioneering company in the Healthcare Technology and Biotechnology sectors, specializing in innovative in vitro diagnostic (IVD) devices. Its advanced technology enables clinicians to rapidly identify and treat infections like sepsis, ensuring timely and effective antibiotic therapy for improved patient outcomes.
Competitors of GenomeKey are Thermo Fisher Scientific, Roche Diagnostics, Abbott Laboratories, Cepheid, Becton, Dickinson and Company (BD), bioMérieux.
What does GenomeKey do?
GenomeKey is a pioneering company in the Healthcare Technology and Biotechnology sectors, specializing in innovative in vitro diagnostic (IVD) devices. Its advanced technology enables clinicians to rapidly identify and treat infections like sepsis, ensuring timely and effective antibiotic therapy for improved patient outcomes.